has been active in the field of pharmaceutical regulatory affairs for more than 20 years. As a team leader, he is responsible for overseeing the regulatory activities of Bionorica SE in the EU, Switzerland, and the USA. In this role, he has extensive expertise in regulatory requirements, variation procedures, and approval strategies. He is also actively involved in various expert committees and maintains regular dialogue with regulatory authorities across Europe.
His academic background began with a degree in Chemistry (equivalent to a Master's degree, Diplom-Chemiker) from the University of Regensburg and the University of Aberdeen. He subsequently earned his PhD in Inorganic and Pharmaceutical Chemistry.